LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

ApoC-III is a proatherogenic protein associated with elevated triglycerides; its deficiency is associated with reduced atherosclerosis. Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases ca...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Brautbar, Ariel, Virani, Salim S., Belmont, John, Nambi, Vijay, Jones, Peter H., Ballantyne, Christie M.
פורמט: Artigo
שפה:Inglês
יצא לאור: The American Society for Biochemistry and Molecular Biology 2012
נושאים:
Patient-Oriented and Epidemiological Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276479/
https://ncbi.nlm.nih.gov/pubmed/22236405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M020404
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים